Your President isn’t going to do anything about drug prices, not domestically and not internationally. Neither will Europe or Asia pay more for medicine. Innovation in medicine does NOT depend on unlimited price gouging–that’s a lazy lie by PhRMA to protect their clients’ profits. Pharma companies can be profitable with price controls and should be competing on EFFICACY and not on marketing.
Also in Industry News
1.5 Million Israelis Using Voluntary Coronavirus Monitoring App
ATS releases new guidance to help clinicians manage COVID-19 patients
Cancer patients face treatment delays and uncertainty as coronavirus cripples hospitals